Enhancing better outcomes

By combining AI, real-time data, and clinical insights, we enable a more personalized, efficient, and connected healthcare experience — one that empowers patients to take informed action, supports providers with intelligent tools, accelerates research and innovation, and expands access to timely, high-quality care.

Empower patients with personalized, trusted information, tools, and prompts that encourage positive health actions.

Support healthcare providers with decision-making tools that streamline workflows and enhance clinical outcomes.

Advance research and drug development by turning fragmented data into actionable real-world evidence for treatments.

Enhance access to quality care by ensuring patients receive timely, accurate, and effective treatments when needed.

At Medicia, we believe that technology should serve humanity. By connecting medical expertise, real-world patient experiences, we are shaping a smarter, more efficient, and more compassionate healthcare ecosystem—where patients are empowered, providers are supported, and outcomes are improved.

Leaders passionate about helping patients

CO-FOUNDER, CEO

Markus Glimm

Markus, co-founder and CEO of Medicia, drives the company’s mission to lead oncology informatics. With over 30 years of experience, he has a proven track record in digital health solutions, especially in oncology. His leadership spans diverse industries, from software to healthcare, and his focus is on empowering patients through innovative technologies. Markus previously co-founded TRxCARE and has worked with global corporations like Siemens and Teletech.

PRESIDENT NORTH AMERICA

Brian Cooley

Brian R. Cooley is a visionary healthcare leader with 30+ years of experience in the life sciences sector. He has successfully commercialized breakthrough products, including genetically engineered insulins and GLP-1 agonists. Brian has held senior roles at major companies like Lilly and Genentech, and in start-ups like Sorrento Therapeutics. His leadership has led to the launch of 12 new drugs and devices and successful licensing deals globally.

CO-FOUNDER, HEAD OF SCIENTIFIC ADVISORY BOARD

Prof. Wee Joo Chng

Professor Wee Joo Chng is a renowned oncology expert and Director of the National University Cancer Institute Singapore. He is also a Senior Principal Investigator at the Cancer Science Institute and a Vice-Dean at the Yong Loo Lin School of Medicine. With over 200 publications, he’s deeply involved in hematology research and clinical trials. His accolades include multiple prestigious awards such as the National Medical Excellence Outstanding Clinician Scientist Award.

CO-FOUNDER, CTO

Frankie Wong

Frankie, Chief Medical Officer at Medicia, focuses on driving digital health solutions for improved patient outcomes. His background in clinical leadership and medical research helps shape Medicia’s patient-centric approach. He works closely with teams to ensure solutions are scientifically grounded and aligned with the latest advancements. Frankie’s expertise is key in developing personalized treatment pathways for better healthcare outcomes.

PRESIDENT EUROPE

Yves Decadt

Yves Decadt is a biotech and pharmaceutical leader with over 25 years of experience. He has held key roles as CEO, Chairman, and Founder, focusing on innovation and sustainability. He began his career at Johnson & Johnson, later leading companies like Medimetrics, Stragen Pharma, and BioLingus. His expertise spans global dealmaking, business development, and advancing treatments in obesity, diabetes, and immunology.

SCIENTIFIC ADVISOR

Prof. Dean Ho

Professor Dean Ho is a leader in biomedical engineering and digital medicine at the National University of Singapore. He heads the Department of Biomedical Engineering and directs the Institute for Digital Medicine. His research focuses on digital platforms and AI technologies, including CURATE.AI, an AI-driven platform for personalized treatments. Professor Ho has received multiple prestigious honors, including election to the US National Academy of Inventors.

Transform your institution's oncology care with AI-driven precision

Get started

Learn more

Your queries, our answers

What makes Medicia different from other healthcare platforms?

Medicia goes beyond generic health platforms by offering medically validated and trusted information tailored to each patient’s unique cancer journey. Unlike conventional solutions, we seamlessly integrate with hospital workflows to provide real-time, personalized guidance—empowering patients, enhancing treatment decisions, and improving care coordination. Our Oncology Cloud AI and Research Cloud AI platforms leverage multimodal AI agents, optimize symptom management, treatment navigation, and predictive analytics, ensuring a data-driven, patient-centered approach to oncology care.

How does Medicia empower patients in their cancer journey?

Medicia provides personalized treatment insights, real-time symptom tracking, and decision support, ensuring patients stay informed, engaged, and in control. By integrating with hospital systems, we enable proactive care, seamless coordination, and shared decision-making, helping patients navigate their journey with confidence.

Is Medicia only for hospitals, or can patients use it directly?

Medicia primarily integrates with hospitals and research institutions to enhance clinical workflows. Patients access Medicia through their healthcare providers, receiving trusted, personalized guidance tailored to their unique journey, backed by real-world data.

How does Medicia’s AI improve cancer treatment?

Oncology Cloud AI analyzes real-world data, patient symptoms, and clinical trends to deliver personalized recommendations, predict complications early, and support data-driven treatment decisions—enhancing patient outcomes and optimizing care.

Does Medicia support clinical research and trials?

Medicia’s Research Cloud AI accelerates clinical trials, enhances real-world evidence, and optimizes treatment research—helping institutions drive breakthroughs faster and improve patient outcomes.

How can hospitals or research institutions collaborate with Medicia?

Hospitals and research institutions can seamlessly integrate Medicia’s platforms to enhance oncology care, clinical workflows, and research capabilities. We offer multiple collaboration models tailored to institutional needs, ensuring a scalable and impactful partnership.

Discover the Journey Behind Medicia’s Innovation

Driving meaningful impact in healthcare

Enhancing better outcomes

At Medicia, we believe that technology should serve humanity. By connecting medical expertise, real-world patient experiences, we are shaping a smarter, more efficient, and more compassionate healthcare ecosystem—where patients are empowered, providers are supported, and outcomes are improved.

Leaders passionate about helping patients

Transform your institution's oncology care with AI-driven precision

A message from our Chief Executive Officer

Your queries, our answers

Are you ready to transform cancer care?